Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00255138
Recruitment Status : Withdrawn
First Posted : November 17, 2005
Last Update Posted : October 31, 2008
Eli Lilly and Company
Information provided by:
Temple University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given